A 48h treatment with either of the two siRNAs against PYCR1 resulted in a significant reduction in cell number in RKO (Fig 3A) and HCT116 (Fig 3B) CRC cell lines. This evidence concerns the gene PYCR1 and colorectal carcinoma.